We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+13.91%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$75.4M
Cap. Flow
+$40.3M
Cap. Flow %
3.87%
Top 10 Hldgs %
26.63%
Holding
265
New
17
Increased
116
Reduced
113
Closed
9

Top Buys

Rank Stock Value
1
IWC icon
iShares Micro-Cap ETF
IWC
+$7.45M
2
SCZ icon
iShares MSCI EAFE Small-Cap ETF
SCZ
+$6.86M
3
TXN icon
Texas Instruments
TXN
+$6.4M
4
RTX icon
RTX Corp
RTX
+$5.93M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$4.31M

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$3.04M
2
VGT icon
Vanguard Information Technology ETF
VGT
+$1.57M
3
MZTI
The Marzetti Company
MZTI
+$1.35M
4
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$1.02M
5
CVS icon
CVS Health
CVS
+$807K

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.73%
2 Healthcare 14.83%
3 Technology 12.03%
4 Consumer Staples 10.78%
5 Financials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOE icon
251
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
$200K 0.02%
+1,854
New +$195K
VYM icon
252
Vanguard High Dividend Yield ETF
VYM
$82.8B
$200K 0.02%
2,337
-45
-2% -$3.76K
LUMN icon
253
Lumen
LUMN
$6.23B
$159K 0.02%
13,222
+48
+0.4% +$667
FBRX icon
254
Forte Biosciences
FBRX
$132K 0.01%
+32
New +$124K
FBIO icon
255
Fortress Biotech
FBIO
$92.4M
$36K ﹤0.01%
+1,333
New +$35K
ATNM icon
256
Actinium Pharmaceuticals
ATNM
$31.7M
$11K ﹤0.01%
762
– –
CRDF icon
257
Cardiff Oncology
CRDF
$73.1M
– –
-10,378
Closed -$43K
CVGW
258
DELISTED
Calavo Growers
CVGW
– –
-2,070
Closed -$203K
OMC icon
259
Omnicom Group
OMC
$24.2B
– –
-2,610
Closed -$201K
TSLA icon
260
Tesla
TSLA
$1.38T
– –
-20,280
Closed -$474K
RDS.B
261
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
– –
-3,763
Closed -$233K
TFCFA
262
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-61,432
Closed -$3.04M
ESL
263
DELISTED
Esterline Technologies
ESL
– –
-2,900
Closed -$344K
ESV
264
DELISTED
Ensco Rowan plc
ESV
– –
-3,723
Closed -$84K
MCF
265
DELISTED
Contango Oil & Gas Co.
MCF
– –
-11,980
Closed -$49K
7 8 9 10
11

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q1 2019 Portfolio in Review

As of Q1 2019, Dowling & Yahnke held 265 positions worth $1.04B, up 7.8% from $965M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke deployed $40.3M of net new capital in Q1 2019, opening 17 new positions and adding to 116 existing holdings. Its largest new stake was Texas Instruments: 61,754 shares worth $6.55M.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vanguard Information Technology ETF, an estimated $1.57M trimmed.

  • Dowling & Yahnke's largest Q1 2019 buy was Texas Instruments: 61,754 shares worth $6.55M.
  • Dowling & Yahnke added most to iShares Micro-Cap ETF in Q1 2019, an estimated $7.45M increase.
  • Dowling & Yahnke's biggest Q1 2019 reduction was Vanguard Information Technology ETF, cutting an estimated $1.57M.
  • Dowling & Yahnke fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $3.04M.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $1.04B portfolio in Q1 2019.
  • Dowling & Yahnke opened 17 new positions and closed 9 in Q1 2019.
  • Dowling & Yahnke's portfolio value rose 7.8% quarter-over-quarter to $1.04B.

Based on Dowling & Yahnke's 13F filing for Q1 2019, filed 30 Apr 2019.